Mechanisms of Transport in Proximal and Distal Tubules
Mechanisms of Transport in Proximal and Distal Tubules
批准号:
7868984
负责人:
William B. Guggino
金额:
$1.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-14 至 2011-08-13
关键词:
AbbreviationsAddressAdultAffectAreaAutosomal Dominant Polycystic KidneyAwardBindingCLCA2 geneCalciumCanis familiarisCell membraneCell surfaceCiliaComplexCystDiseaseDistalEndoplasmic ReticulumFigs - dietaryGenesHamstersHealthImmunoblottingImmunoprecipitationInositolIntegral Membrane ProteinIonsKidneyKidney FailureLeadMDCK cellMechanicsMediatingMutationOocytesOvaryPKD2 genePKD2 proteinPathogenesisPathway interactionsPlasmaPolycystic Kidney DiseasesProprotein Convertase 1Proprotein Convertase 2ProteinsRegulationRoleRouteRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSTIM1 geneSignal PathwaySignal TransductionThapsigarginXenopus oocytegene functionkidney cellmouse modelmutantpublic health relevancereceptorreceptor functiontripolyphosphatewater channel
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autosomal dominant polycystic kidney disease arises from mutations in either the PKD1 or the PKD2 gene which encode PC1 or 2. Although it is increasing clear that PC1 is expressed at the plasma membrane and the primary cilium, the cellular localization of PC2 has been controversial. PC2 localizes to the ER, the plasma membrane, and the primary cilium. A popular hypothesis is that PC1 acts as a mechanical receptor and PC2 as a Ca2+ influx channel in the primary cilium to sense renal flow. It has also been suggested that PC2 functions as an intracellular Ca2+ channel. In addition, evidence suggests that PC1 mutants can cause additional mis-localization of PC2 from the cell surface to the ER, which might also contribute even further to the pathogenesis of ADPKD. Therefore, it is important to investigate the role of the ER localized PC2 in regulating intracellular Ca2+ signaling. We propose that PC1 and 2 operate at the ER and at the plasma membrane in concert with the primary cilium to regulate cytosolic Ca2+. Our studies indicate that both PC1 & 2 functionally interact with the IP3 receptor (IP3R) to modulate intracellular Ca2+ signaling. IP3 mediated intracellular Ca2+ signaling is one of the most important intracellular signaling pathways. We also show that a fragment of PC1 which we call PEC inhibits Ca2+ dependent Cl- currents in oocytes suggesting that it inhibits Ca2+ entry. The fragment coimmunoprecipitates with a component of the store operate Ca2+ entry pathway, STIM1. The overall hypothesis is that PC1 & 2 have a precise role in setting the range of intracellular Ca2+ concentrations over which Ca2+ is released from IP3R and simultaneously inhibiting SOCE. We speculate that PC1 inhibition of store-operated Ca2+ entry is necessary to poise renal cells for Ca2+ influx via the primary cilium as a major route of Ca2+ entry. The proposal has three essential parts: Part I. How specifically do the polycystins modulate ER Ca2+ release? Part II. Do the polycystins regulate store-operated Ca2+ entry? Part III. What is the role of IP3R and store-operated calcium entry in tubule and cyst formation? The overall focus of the past 25 years has been on the mechanisms of transport in proximal and distal tubules. During the tenure of this current award, we made fundamental discoveries regarding how ions move through aquaporin water channels and how PC-1 & 2 form a functional complex. We expanded the previous scope into the area of mouse models. The current application takes a new direction into the area of intracellular Ca2+ signaling.
PUBLIC HEALTH RELEVANCE
Autosomal dominant polycystic kidney disease, a major cause of kidney failure, arises from mutations in more that one gene. When the polycystic kidney genes function abnormally, intracellular calcium is not regulated properly. Thus, understanding normal and abnormal calcium regulation in health and disease, respectively, will ultimately lead to new ways of treating this serious disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expression Core
-
批准号:7669757
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2009
-
负责人:William B. Guggino
-
依托单位:
Repeat dosing of adeno-associated viral vectors
-
批准号:7669749
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2009
-
负责人:William B. Guggino
-
依托单位:
CFTR/Regulation of CL Secretion in Normal and CF Airways
-
批准号:7824134
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2009
-
负责人:William B. Guggino
-
依托单位:
Administrative Core
-
批准号:7669759
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2009
-
负责人:William B. Guggino
-
依托单位:
Outward Trafficking of CFTR
-
批准号:8543708
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2006
-
负责人:William B. Guggino
-
依托单位:
Outward Trafficking of CFTR
-
批准号:7759027
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2006
-
负责人:William B. Guggino
-
依托单位:
Outward Trafficking of CFTR
-
批准号:8134431
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2006
-
负责人:William B. Guggino
-
依托单位:
Outward Trafficking of CFTR
-
批准号:8326229
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2006
-
负责人:William B. Guggino
-
依托单位:
Outward Trafficking of CFTR
-
批准号:8379310
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2006
-
负责人:William B. Guggino
-
依托单位:
Core--Expression
-
批准号:6853364
-
项目类别:
-
资助金额:$10.67万
-
财政年份:2004
-
负责人:William B. Guggino
-
依托单位:
Administrative
-
批准号:6853366
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2004
-
负责人:William B. Guggino
-
依托单位:
Repeat Dosing of Adeno-Associated Viral Vectors
-
批准号:6853341
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2004
-
负责人:William B. Guggino
-
依托单位:
CORE--EXPRESSION
-
批准号:6318399
-
项目类别:
-
资助金额:$27.1万
-
财政年份:2000
-
负责人:William B. Guggino
-
依托单位:
REPEAT DOSING OF ADENO-ASSOCIATED VIRAL VECTORS
-
批准号:6318397
-
项目类别:
-
资助金额:$27.1万
-
财政年份:2000
-
负责人:William B. Guggino
-
依托单位:
REPEAT DOSING OF ADENO-ASSOCIATED VIRAL VECTORS
-
批准号:6110305
-
项目类别:
-
资助金额:$27.1万
-
财政年份:1999
-
负责人:William B. Guggino
-
依托单位:
CORE--EXPRESSION
-
批准号:6110307
-
项目类别:
-
资助金额:$27.1万
-
财政年份:1999
-
负责人:William B. Guggino
-
依托单位:
INTERACTION OF CFTR AND ORCC
-
批准号:6105641
-
项目类别:
-
资助金额:$12.76万
-
财政年份:1998
-
负责人:William B. Guggino
-
依托单位:
CORE--EXPRESSION
-
批准号:6242303
-
项目类别:
-
资助金额:$13.57万
-
财政年份:1997
-
负责人:William B. Guggino
-
依托单位:
Gene and Pharmacological Therapies for Cystic Fibrosis
-
批准号:8479396
-
项目类别:
-
资助金额:$105.62万
-
财政年份:1997
-
负责人:William B. Guggino
-
依托单位:
Gene and Pharmacological Therapies for Cystic Fibrosis
-
批准号:7631642
-
项目类别:
-
资助金额:$116.36万
-
财政年份:1997
-
负责人:William B. Guggino
-
依托单位:
海外基金